Drug composition and coating
US11529441B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jan 3, 2020 |
| Grant date | Dec 20, 2022 |
| Priority date | — |
| Expiry date | Jan 3, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2420/06
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
According to the invention there is provided inter alia a medical device for delivering a paclitaxel to a tissue, the device the device having a coating layer applied to a surface of the device, the coating layer comprising components i), ii) and iii), whereincomponent i) is a therapeutic agent which is paclitaxel; andcomponent ii) is urea or a pharmaceutically acceptable salt thereof, or a urea derivative or a pharmaceutically acceptable salt thereof; andcomponent iii) is succinic acid, glutaric acid or caffeine, or a pharmaceutically acceptable salt of any one thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.